Literature DB >> 12112724

Reliability of the self-report version of the panic disorder severity scale.

Patricia R Houck1, David A Spiegel, M Katherine Shear, Paola Rucci.   

Abstract

The interview-administered Panic Disorder Severity Scale (PDSS) has been demonstrated to be a reliable and valid measurement of panic disorder severity. The purpose of this paper is to report on the reliability and usefulness of the self-report form (PDSS-SR). The PDSS and PDSS-SR were administered to 108 psychiatric outpatients with and without panic disorder. The internal consistency of the instruments was analyzed with Cronbach's alpha. Test-retest reliability was assessed on 25 of these subjects by using intraclass correlation coefficient (ICC). In addition, decrease in panic symptoms was measured after cognitive-behavioral treatment (CBT) treatment on 27 subjects. Cronbach's alpha was.917 for PDSS-SR and.923 for the PDSS. The PDSS-SR had good test-retest reliability (ICC=0.81) and was sensitive to change with treatment, with a mean decrease of 7.3 (S.D.=5.1). The self-report version of the PDSS is a reliable format, which could be useful in clinical and research settings. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12112724     DOI: 10.1002/da.10049

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  97 in total

1.  The effects of extraverted temperament on agoraphobia in panic disorder.

Authors:  Anthony J Rosellini; Amy E Lawrence; Joseph F Meyer; Timothy A Brown
Journal:  J Abnorm Psychol       Date:  2010-05

2.  Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI).

Authors:  Ronald C Kessler; Jamie Abelson; Olga Demler; Javier I Escobar; Miriam Gibbon; Margaret E Guyer; Mary J Howes; Robert Jin; William A Vega; Ellen E Walters; Philip Wang; Alan Zaslavsky; Hui Zheng
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  Applying the Quadruple Process model to evaluate change in implicit attitudinal responses during therapy for panic disorder.

Authors:  Elise M Clerkin; Christopher R Fisher; Jeffrey W Sherman; Bethany A Teachman
Journal:  Behav Res Ther       Date:  2013-11-10

4.  Intolerance of uncertainty: a common factor in the treatment of emotional disorders.

Authors:  James F Boswell; Johanna Thompson-Hollands; Todd J Farchione; David H Barlow
Journal:  J Clin Psychol       Date:  2013-02-04

5.  The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Robert Jin; Ayelet Meron Ruscio; Katherine Shear; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2006-04

6.  Mechanisms of change in cognitive behavioral therapy for panic disorder: the unique effects of self-efficacy and anxiety sensitivity.

Authors:  Matthew W Gallagher; Laura A Payne; Kamila S White; Katherine M Shear; Scott W Woods; Jack M Gorman; David H Barlow
Journal:  Behav Res Ther       Date:  2013-09-12

7.  Age differences in treatment response to a collaborative care intervention for anxiety disorders.

Authors:  Julie Loebach Wetherell; Andrew J Petkus; Steven R Thorp; Murray B Stein; Denise A Chavira; Laura Campbell-Sills; Michelle G Craske; Cathy Sherbourne; Alexander Bystritsky; Greer Sullivan; Peter Roy-Byrne
Journal:  Br J Psychiatry       Date:  2013-04-11       Impact factor: 9.319

8.  The National Comorbidity Survey Replication (NCS-R): background and aims.

Authors:  Ronald C Kessler; Kathleen R Merikangas
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

9.  Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial.

Authors:  Filip Smit; Godelief Willemse; Peter Meulenbeek; Marc Koopmanschap; Anton van Balkom; Philip Spinhoven; Pim Cuijpers
Journal:  Cost Eff Resour Alloc       Date:  2009-04-24

10.  Early intervention in panic: randomized controlled trial and cost-effectiveness analysis.

Authors:  Peter Meulenbeek; Godelief Willemse; Filip Smit; Anton van Balkom; Philip Spinhoven; Pim Cuijpers
Journal:  Trials       Date:  2008-11-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.